Benicar

• Angiotensin II Type 1 Receptor Blockers
• Antihypertensive Agents
• ATC:C09CA08

• Benicar
• Olmesartan medoximil
• Olmetec

• No information avaliable

C₂₉H₃₀N₆O₆

http://www.rxlist.com/cgi/generic/benicar.htm

Benicar FDA

Benicar MSDS

No information avaliable

558.585 g/mol

175-180 ^oC

No information avaliable

Solid

5.202

Tablet

For the treatment of hypertension

Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.

Bioavailability is about 26%. Food does not affect the bioavailability of olmesartan.

Symptoms of overdose include dehydration (dry mouth, excessive thirst, muscle pain or cramps, nausea and vomiting, weakness), dizziness, low blood pressure, and slow or irregular heartbeat.

Humans and other mammals